BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26688707)

  • 1. Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases.
    Heaney RM; Shields C; Mulsow J
    World J Gastrointest Oncol; 2015 Dec; 7(12):445-54. PubMed ID: 26688707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete Cytoreduction of Colorectal Cancer Peritoneal Metastases: Survival Outcomes by a Cytoreduction Score.
    Sugarbaker PH; Chang D
    Visc Med; 2022 Apr; 38(2):99-108. PubMed ID: 35614894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
    Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.
    El-Nakeep S; Rashad N; Oweira H; Schmidt J; Helbling D; Giryes A; Petrausch U; Mehrabi A; Decker M; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):249-258. PubMed ID: 28099818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Paul BK; Ihemelandu C; Sugarbaker PH
    Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
    Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
    World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Chang D; Koslowe P
    Cancer Treat Res; 1996; 81():89-104. PubMed ID: 8834578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
    Jeon Y; Park EJ; Lim JH; Baik SH
    World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review.
    van Oudheusden TR; Nienhuijs SW; Luyer MD; Nieuwenhuijzen GA; Lemmens VE; Rutten HJ; de Hingh IH
    Eur J Surg Oncol; 2015 Oct; 41(10):1269-77. PubMed ID: 26175345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    Alzahrani NA; Valle SJ; Fisher OM; Sugarbaker PH; Yonemura Y; Glehen O; Goere D; Honore C; Brigand C; de Hingh I; Verwaal VJ; Deraco M; Baratti D; Kusamura S; Pocard M; Piso P; Maerz L; Marchal F; Moran B; Levine EA; Dumont F; Pezet D; Abboud K; Kozman MA; Liauw W; Morris DL;
    J Surg Oncol; 2019 Mar; 119(3):336-346. PubMed ID: 30554404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
    Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
    Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy and Prophylaxis of Peritoneal Metastases from Colorectal Cancer.
    Němec L; Tomášek J; Šefr R
    Klin Onkol; 2019; 32(5):338-344. PubMed ID: 31610665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.
    Pallas N; Karamveri C; Kyziridis D; Hristakis C; Kyriakopoulos V; Kalakonas A; Vaikos D; Tentes AK
    J BUON; 2017; 22(6):1547-1553. PubMed ID: 29332351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview.
    Arjona-Sánchez A; Medina-Fernández FJ; Muñoz-Casares FC; Casado-Adam A; Sánchez-Hidalgo JM; Rufián-Peña S
    World J Gastrointest Oncol; 2014 Oct; 6(10):407-12. PubMed ID: 25320657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.